About 90% of CMML patients have somatic mutations including TET2, SRSF2, and ASXL1 mutations7,18–20 with an average of 14 per patient21, yet none of them are specific to the disease. The gene discussed is ASXL1; the disease is chronic myelomonocytic leukemia.